<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药闻社 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-18T23:53:57+08:00</updated>
  <subtitle>《药闻社》以重磅深度调查报道的形式，为投资者深度剖析具体企业的投资价值与风险，为产业资本与金融资本的融合提供最透明的信息依据。左手医药健康，右手资本市场，大健康产业第一深度新媒体。不定期更新，只发重磅。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>14亿理财！一次性医械巨头IPO为何遭拒？</title>
    <updated>2021-01-18T21:58:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/Dv3mb5QfDugnpr0NCXUC7g</id>
    <link href="https://mp.weixin.qq.com/s/Dv3mb5QfDugnpr0NCXUC7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>熙象科技完成近千万元天使轮融资;​​原能医学实现A轮融资逾2亿元；百明信康完成近2亿元A轮融资</title>
    <updated>2021-01-18T21:58:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/fQFqchKq-mcWGXgtNYEofQ</id>
    <link href="https://mp.weixin.qq.com/s/fQFqchKq-mcWGXgtNYEofQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>天花板重构，眼科器械龙头进军医美蓝海！幕后推手竟是A股玻尿酸巨头前CEO？</title>
    <updated>2021-01-17T22:18:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/BXkfDwHTre_V2IxG0VZB0Q</id>
    <link href="https://mp.weixin.qq.com/s/BXkfDwHTre_V2IxG0VZB0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最高降幅96.34%！又一高值耗材集采近覆盖全国，市场迎来全面洗牌！</title>
    <updated>2021-01-16T20:01:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/yyNWOjVa6HrVuUqpjXCsnA</id>
    <link href="https://mp.weixin.qq.com/s/yyNWOjVa6HrVuUqpjXCsnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康希诺疫苗在俄三期试验中：92.5%志愿者显示出高水平抗体</title>
    <updated>2021-01-15T21:13:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/RSeQX1FQ8579NdNanlh9HQ</id>
    <link href="https://mp.weixin.qq.com/s/RSeQX1FQ8579NdNanlh9HQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国药股份回应高管辞任</title>
    <updated>2021-01-14T20:04:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/8H_RWoKkdrIWQEVxhrM0Ow</id>
    <link href="https://mp.weixin.qq.com/s/8H_RWoKkdrIWQEVxhrM0Ow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺令生物完成数千万元A轮融资;​​药极客完成1000万元种子轮融资</title>
    <updated>2021-01-14T20:04:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/1V4OzxIREH2jTjMv2-x1mA</id>
    <link href="https://mp.weixin.qq.com/s/1V4OzxIREH2jTjMv2-x1mA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>对手遇阻凸显甘李护城河 市值悄然增加400个小目标</title>
    <updated>2021-01-13T21:44:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/ALuc_t7d0bHG3vnB746ODw</id>
    <link href="https://mp.weixin.qq.com/s/ALuc_t7d0bHG3vnB746ODw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>22亿美元创国内药物授权交易记录  百济PD-1获诺华垂青</title>
    <updated>2021-01-13T21:44:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/asnoB-nxm9930mMXmD9PnA</id>
    <link href="https://mp.weixin.qq.com/s/asnoB-nxm9930mMXmD9PnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>高瓴A股又有新动作！这次看上了这个细分行业的龙二？暴露了什么信号？</title>
    <updated>2021-01-11T22:23:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/4zeSS9mGPnSQ2sA-MjhAHg</id>
    <link href="https://mp.weixin.qq.com/s/4zeSS9mGPnSQ2sA-MjhAHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>心擎医疗获超亿元B轮融资;​睿心医疗完成近3亿元B轮融资</title>
    <updated>2021-01-11T22:23:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/JqEP_pDrFN9gARtmN9h4AA</id>
    <link href="https://mp.weixin.qq.com/s/JqEP_pDrFN9gARtmN9h4AA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国产率不足13%的器械新战场！龙头已率先上市，微创、信立泰亦跑马圈地！</title>
    <updated>2021-01-10T21:12:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/bLPl5kV2Qi8K9iQyRf72Dg</id>
    <link href="https://mp.weixin.qq.com/s/bLPl5kV2Qi8K9iQyRf72Dg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>十年迷茫科伦药业：曾与恒瑞并肩300亿市值 如今相差30倍</title>
    <updated>2021-01-08T17:13:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/6Kf6rUsRVASq7r-WLoJx6Q</id>
    <link href="https://mp.weixin.qq.com/s/6Kf6rUsRVASq7r-WLoJx6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>祸不单行！济民制药连续10个跌停后，又因信披违规收警示函</title>
    <updated>2021-01-07T23:53:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/rrlsNkmTj2tZpQx1AtZDZg</id>
    <link href="https://mp.weixin.qq.com/s/rrlsNkmTj2tZpQx1AtZDZg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>优脑银河完成上亿元Pre-A轮融资;​恒升医疗完成近3亿元A轮融资;​​火石创造A轮融资近亿元</title>
    <updated>2021-01-07T23:53:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/LJqNuvx5GcHmHIG5T44oZA</id>
    <link href="https://mp.weixin.qq.com/s/LJqNuvx5GcHmHIG5T44oZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>